The Role of Tumor-Free Status in Repeat Resection Before Intravesical Bacillus Calmette-Guerin for High Grade Ta, T1 and CIS Bladder Cancer

Journal of Urology

Volumn 183, Issue 6, 2010, Pages 2161-2164

  Guevara, Andrea ^a   Salomon, Laurent ^a   Allory, Yves ^a   Ploussard, Guillaume ^a   de la Taille, Alexandre ^a   Paul, Alexandre ^a   Yiou, René ^a   Hoznek, Andras ^a   Dahan, Mickaël ^a   Abbou, Claude Clément ^a   Vordos, Dimitri ^a  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE PARIS   (France)

Author keywords

local; Mycobacterium bovis; neoplasm recurrence; reoperation; urinary bladder; urinary bladder neoplasms

Indexed keywords

ANTINEOPLASTIC AGENT; BCG VACCINE; MITOMYCIN C;

ADULT; AGED; ARTICLE; BLADDER CANCER; CANCER GRADING; CANCER GROWTH; CANCER RECURRENCE; CANCER SURVIVAL; CONTROLLED STUDY; CYSTECTOMY; DISEASE FREE SURVIVAL; DRUG RESPONSE; DRUG TREATMENT FAILURE; FEMALE; HUMAN; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; MUSCLE DISEASE; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; REOPERATION; TRANSURETHRAL RESECTION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRAVESICAL; ADULT; AGED; AGED, 80 AND OVER; BCG VACCINE; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEOPLASM STAGING; PREOPERATIVE CARE; REOPERATION; RETROSPECTIVE STUDIES; URINARY BLADDER NEOPLASMS;

EID: 77951877996     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2010.02.026     Document Type: Article

References (18)

1. Hall M., Chang S., Dalbagni G., et al. Guidelines for the management of nonmuscle invasive bladder cancer (stages Ta, T1, and Tis): 2007 update. J Urol 178 (2007) 2314
2. Babjuk M., Oosterlinck W., Sylvester R., et al. European Association of Urology Guidelines on Ta, T1 (Non-Muscle Invasive) Bladder Cancer. Update March 2008 (2008), European Association of Urology, Amhem, The Netherlands
3. Persad R., Lamm D., Brausi M., et al. Current approaches to the management of non-muscle invasive bladder cancer: comparison of current guidelines and recommendations. Eur Urol 7 suppl. (2008) 637
4. Nieder A.M., Brausi M., Lamm D., et al. Management of stage T1 tumors of the bladder: international consensus panel. Urology 66 (2005) 75
5. Brauers A., Buettner R., and Jakse G. Second resection and prognosis of primary high risk superficial bladder cancer: is cystectomy often too early?. J Urol 165 (2001) 808
6. Herr H.W. Restaging transurethral resection of high risk superficial bladder cancer improves the initial response to bacillus Calmette-Guerin therapy. J Urol 174 (2005) 2134
7. Herr H.W., and Donat S.M. A re-staging transurethral resection predicts early progression of superficial bladder cancer. BJU Int 97 (2006) 1194
8. Herr H.W. Does cystoscopy correlate with histology of recurrent papillary tumors of the bladder?. BJU Int 88 (2001) 83
9. Herr H.W. The value of second transurethral resection in evaluating patients with bladder tumor. J Urol 162 (1999) 74
10. Divrik T., Yildrim Ü., Eroglu A., et al. Is a second transurethral resection necessary for newly diagnosed pT1 bladder cancer?. J Urol 175 (2006) 1258
11. Lamm D.L., Blumenstein B.A., Crissman J.D., et al. Maintenance bacillus Calmette-Guérin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: a randomized Southwest Oncology Group Study. J Urol 163 (2000) 1124
12. Jakse G., Algaba F., Malmström P.U., et al. A second-look TUR in T1 transitional cell carcinoma: why?. Eur Urol 45 (2004) 539
13. Fitzpatrick J.M., West A.B., Butler M.R., et al. Superficial bladder tumors: the importance of recurrence pattern following initial resection. J Urol 135 (1986) 920
14. Brausi M., Colette L., Kurth K.H., et al. Variability in recurrence rate after at first follow-up cystoscopy after TUR in stage TaT1 transitional carcinoma of the bladder: a combined analysis of seven EORTC studies. Eur Urol 41 (2002) 523
15. Sylvester R.J., van der Mejden A.P., Witjes J.A., et al. High grade Ta urothelial carcinoma and carcinoma in situ of the bladder. Urology 66 (2005) 90
16. Nieder A.M., Brausi M., Lamm D., et al. Management of stage T1 tumors of the bladder: international consensus panel. Urology 66 (2005) 108
17. Sylvester R.J., van der Meijden, and Lamm D.L. Intravesical bacillus Calmette-Guérin reduces risk of progression in patients with superficial bladder cancer: a combined analysis of the published results of randomized clinical trials. J Urol 168 (2002) 1964
18. Herr H.W., and Dalbagni G. Defining bacillus Calmette-Guérin refractory superficial bladder tumors. J Urol 169 (2003) 1706